SCHEMBL15415495

SCHEMBL15415495

OC1CCC(C2(CCl)Nc3ccc(Cl)cc3N2)C1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.40
▸ LIMK1 P53667 1/20 0.40
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CMA1 P23946 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ CYP46A1 Q9Y6A2 1/20 0.31
▸ PDE7A Q13946 2/20 0.30
▸ MAP3K14 Q99558 1/20 0.30
▸ HTR3E A5X5Y0 1/20 0.30
▸ HTR3B O95264 1/20 0.30
▸ HTR3A P46098 1/20 0.30
▸ HTR3D Q70Z44 1/20 0.30
▸ HTR3C Q8WXA8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15416052 0.74 CHEK1 (0.37) CHEK1LIMK1MEN1KMT2A
SCHEMBL15416013 0.73 TP53 (0.38) CHEK1LIMK1MEN1KMT2A
SCHEMBL15416741 0.68 CNR1 (0.40) MEN1KMT2A
SCHEMBL4786389 0.66 CHEK1 (0.50) CHEK1LIMK1CMA1AHRPDE7A
SCHEMBL11386072 0.60 CHEK1 (0.55) CHEK1LIMK1CMA1AHRHTR3A
SCHEMBL9571241 0.59 PDE7A (0.49) MEN1KMT2APDE7A
SCHEMBL23092730 0.58 CHEK1 (0.39) CHEK1LIMK1CMA1AHR
SCHEMBL3966441 0.56 BRD4 (0.46) MEN1KMT2ACMA1AHRPDE7A
SCHEMBL19905814 0.56 AHR (0.43) CMA1AHRHTR3EHTR3BHTR3A
SCHEMBL13868943 0.56 CHEK1 (0.59) CHEK1LIMK1CMA1AHRHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 — — EP disclosed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 — — WO disclosed
Send feedback